Evaluation of the Safety, Tolerability, Pharmacokinetics, and Activity of GS-9450 in Subjects With Chronic HCV
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the safety, tolerability, pharmacokinetics (studies
how the body processes a drug), and initial activity of GS-9450 in preventing liver damage
due to scarring, or fibrosis, caused by Hepatitis C Virus (HCV) infection.